Search

Author/Creator Raeman F author non-byline.

1. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Issue 1 (30th October 2014)

Authors:
Verschueren, P; De Cock, D; Corluy, L; Joos, R; Langenaken, C; Taelman, V; Raeman, F; Ravelingien, I; Vandevyvere, K; Lenaerts, J; Geens, E; Geusens, P; Vanhoof, J; Durnez, A; Remans, J; Vander Cruyssen, B; Van Essche, E; Sileghem, A; De Brabanter, G; Joly, J
Other Names:
Maeyaert B author non-byline.; De Brabanter G author non-byline.; Devinck M author non-byline.; Langenaken C author non-byline.; Lenaerts J author non-byline.; Corluy L author non-byline.; Remans J author non-byline.; Vander Cruyssen B author non-byline.; Ravelingien I author non-byline.; Van Ess...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 1(2015)
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search